戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 een mapped onto the structure of short chain acyl-CoA dehydrogenase.
2  of mitochondrial medium- or very long-chain acyl-CoA dehydrogenase.
3 probe of the active site in the medium chain acyl-CoA dehydrogenase.
4  not require involvement of the medium-chain acyl-CoA dehydrogenase.
5 g thioester polarization in the medium chain acyl-CoA dehydrogenase.
6 such an intermediate in the biogenesis of an acyl-CoA dehydrogenase.
7 ogenase family except for IVD and long-chain acyl-CoA dehydrogenase.
8                 The enzyme is a homologue of acyl-CoA dehydrogenase.
9 amate which acts as the base in medium chain acyl-CoA dehydrogenase.
10 11 constitute a distinct class of eucaryotic acyl CoA dehydrogenases.
11                   FkbI has a similar fold to acyl-CoA dehydrogenases.
12 not as favorable as that observed with other acyl-CoA dehydrogenases.
13 oxylation reaction which is unique among the acyl-CoA dehydrogenases.
14 and has high levels of homology with various acyl-CoA dehydrogenases.
15 s which induce competitive inhibition of the acyl-CoA dehydrogenases.
16        The same mechanism may regulate other acyl-CoA dehydrogenases.
17 e dehydrogenase (PDH), citrate synthase, and acyl-CoA dehydrogenases.
18 ng induces a large enzyme potential shift in acyl-CoA dehydrogenases.
19 ehyde dehydrogenase 2 (ALDH2), ATP synthase, acyl-CoA dehydrogenase, 3-ketoacyl-CoA thiolase, and man
20                                              Acyl-CoA dehydrogenase 9 (ACAD9) is a recently identifie
21                                              Acyl-CoA dehydrogenase 9 (ACAD9) is an assembly factor f
22      Medium-chain acyl-CoA dehydrogenase and acyl-CoA dehydrogenase 9, two related enzymes with lysin
23 ased acetylation of mitochondrial long-chain acyl-CoA dehydrogenase, a known SIRT3 deacetylation targ
24       The flavoenzyme is a new member of the acyl-CoA dehydrogenase (ACAD) family, but it does not re
25 oned cDNA showed that NOA is a member of the acyl-CoA dehydrogenase (ACAD) superfamily.
26 rally distinct subfamily of acyl coenzyme A (acyl-CoA) dehydrogenase (ACAD) enzymes that are alpha2be
27 nalysis indicated that, like very-long-chain acyl-CoA dehydrogenase, ACAD-9 is a dimer, in contrast t
28                            The expression of acyl-CoA dehydrogenase ACADM, the first enzyme involved
29                                          The acyl-CoA dehydrogenases (ACADs) are enzymes that catalyz
30          However, their oxidation in vivo by acyl-CoA dehydrogenases (ACADs) that catalyze the first
31 lock in B-oxidation at the step catalyzed by acyl-CoA dehydrogenases (ACADs), which in other organism
32 l side chain metabolism requires one or more acyl-CoA dehydrogenases (ACADs).
33 ogenase (VLCAD) is a member of the family of acyl-CoA dehydrogenases (ACADs).
34 (MCD) belongs to the family of FAD-dependent acyl-CoA dehydrogenase (ACD) and is a key enzyme of the
35 nserved Caenorhabditis elegans gene acdh-11 (acyl-CoA dehydrogenase [ACDH]) facilitates heat adaptati
36                                              Acyl-CoA dehydrogenases (ACDs) are a family of flavoenzy
37 of the enzymes discussed in this review [the acyl-CoA dehydrogenases (ACDs), CDP-6-deoxy-l-threo-d-gl
38                           The measurement of acyl-CoA dehydrogenase activities is an essential part o
39                                              Acyl-CoA dehydrogenase activities were measured in rat s
40 nthesis of the substrates used for measuring acyl-CoA dehydrogenase activities; however, the yields a
41 cid oxidation enzyme integrity, medium-chain acyl-CoA dehydrogenase activity and fat oxidation are el
42  differentiation by attenuating medium-chain acyl-CoA dehydrogenase activity and that inhibition of t
43 confirmed that conversion is performed by an acyl-CoA dehydrogenase and a subsequent hydratase yieldi
44                                 Medium-chain acyl-CoA dehydrogenase and acyl-CoA dehydrogenase 9, two
45 he powerful epoxyketone residue involving an acyl-CoA dehydrogenase and an unconventional free-standi
46  and PPARalpha-regulated genes (medium chain acyl-CoA dehydrogenase and pyruvate dehydrogenase kinase
47  or medium-chain acyl CoAs, and medium-chain acyl-CoA dehydrogenase and short-chain acyl-CoA dehydrog
48 y to receive electrons from the medium chain acyl-CoA dehydrogenase and the glutaryl-CoA dehydrogenas
49 atty acids by the mitochondrial medium-chain acyl-CoA dehydrogenase and the peroxisomal acyl-CoA oxid
50                                              Acyl-CoA dehydrogenases and acyl-CoA oxidases are two cl
51  a tetrameric enzyme that shares a fold with acyl-CoA dehydrogenases and class D flavin-containing mo
52 is similar to those of previously determined acyl-CoA dehydrogenases and consists of an NH2-terminal
53 7 and Phe-320, which are conserved among all acyl-CoA dehydrogenases and coordinate the enzyme-bound
54  base in medium-chain (MCAD) and short-chain acyl-CoA dehydrogenases and is conserved in all members
55 f these ORFs, two had sequence similarity to acyl-CoA dehydrogenases and polyketide synthases, respec
56 lism (eg, pyruvate dehydrogenase complex and Acyl-CoA dehydrogenase) and enzymes involved in electron
57 s, such as acetyl-CoA synthetase, long-chain acyl-CoA dehydrogenase, and 3-hydroxy-3-methylglutaryl-C
58 xidation, such as cytochrome c, medium-chain acyl-CoA dehydrogenase, and adipocyte protein 2.
59 ptide, beta myosin heavy chain, medium chain acyl-CoA dehydrogenase, and adrenomedullin correlate equ
60 nge the basal acyl-CoA oxidase, medium chain acyl-CoA dehydrogenase, and malic enzyme mRNA levels.
61 topropionic acid, an inhibitor of long chain acyl-CoA dehydrogenase, and partially inhibited by 2-tet
62 at liver is compared to that of medium chain acyl-CoA dehydrogenase, and the structural basis for the
63 nitine palmitoyl transferase-1, medium-chain acyl-CoA dehydrogenase, and uncoupling protein 3), calci
64 chain acyl-CoA dehydrogenase and short-chain acyl-CoA dehydrogenase are unable to catalyze oxidation
65 y, it appears that ACAD9 and very-long-chain acyl-CoA dehydrogenase are unable to compensate for each
66 lf-reaction of ETF with porcine medium chain acyl-CoA dehydrogenase are unaltered when alphaT244M ETF
67                                          The acyl-CoA dehydrogenases are a family of flavin adenine d
68                                          The acyl-CoA dehydrogenases are a family of flavoenzymes wit
69                                          The acyl-CoA dehydrogenases are a family of mitochondrial fl
70                                          The acyl-CoA dehydrogenases are a family of multimeric flavo
71 t is generally held that the active sites of acyl-CoA dehydrogenases are desolvated when substrate bi
72  the suppression of oxygen reactivity in the acyl-CoA dehydrogenases are discussed.
73 eview examines the structure of medium chain acyl-CoA dehydrogenase, as a representative of the dehyd
74 ious work demonstrated that the medium-chain acyl-CoA dehydrogenase both bioactivates and is inhibite
75 inactivation of short chain and medium chain acyl-CoA dehydrogenases by this inhibitor and related 2-
76 miting step in the inactivation of the other acyl-CoA dehydrogenases can involve the abstraction of a
77 nes encoding key mitochondrial (medium-chain acyl-CoA dehydrogenase, carnitine palmitoyltransferase I
78                             The medium chain acyl-CoA dehydrogenase catalyzes the flavin-dependent ox
79     The crystal structure of rat short chain acyl-CoA dehydrogenase complexed with the inhibitor acet
80  Children with medium-chain acyl-coenzyme A (acyl-CoA) dehydrogenase defects can metabolize fatty aci
81                                     Multiple acyl-CoA dehydrogenase deficiencies (MADDs) are a hetero
82 tine are effective in some cases of multiple acyl-CoA dehydrogenase deficiency and primary carnitine
83 ciencies in ETF or ETF-QO result in multiple acyl-CoA dehydrogenase deficiency, a human metabolic dis
84 te methyltransferase deficiency, short-chain acyl-CoA dehydrogenase deficiency, adrenoleukodystrophy,
85       In three patients with very-long-chain acyl-CoA dehydrogenase deficiency, this treatment led ra
86                                    Two fatty acyl-CoA dehydrogenases (designated FadE1 and FadE2) are
87 on transferring flavoprotein and short chain acyl-CoA dehydrogenase-electron transferring flavoprotei
88 sly expressed and purified FadE28-FadE29, an acyl-CoA dehydrogenase encoded by the igr operon, cataly
89           Rat and human short/branched chain acyl-CoA dehydrogenases exhibit key differences in subst
90                      Changes in medium-chain acyl-CoA dehydrogenase expression and acylcarnintine flu
91  beta-oxidation gene (medium and short chain acyl-CoA dehydrogenase) expression levels remain unchang
92 nases and is conserved in all members of the acyl-CoA dehydrogenase family except for IVD and long-ch
93 atalytically essential glutamate base in the acyl-CoA dehydrogenase family is found either on the loo
94                                      When an acyl-CoA dehydrogenase family member, human short chain
95 elements: the nuclear pore complex (NPC) and acyl-CoA dehydrogenase family member-10 (ACAD10).
96 y been identified as being homologous to the acyl-CoA dehydrogenase family of enzymes.
97 -CoA dehydrogenase is the only member of the acyl-CoA dehydrogenase family with a cationic residue, A
98 ch is a tyrosine in all other members of the acyl-CoA dehydrogenase family, is important for conferri
99 n example of convergent evolution within the acyl-CoA dehydrogenase family, leading to the independen
100 activity, a property of other members of the acyl-CoA dehydrogenase family.
101 tional discrimination between members of the acyl-CoA dehydrogenase family.
102 ely high oxidase activity of the short chain acyl-CoA dehydrogenase from the obligate anaerobe Megasp
103  the targeted inactivation of the long chain acyl CoA dehydrogenase gene (Acadl) are also sensitive t
104 ement (NRRE-1) derived from the medium chain acyl-CoA dehydrogenase gene promoter and nuclear protein
105 susceptibility variations in the short-chain acyl-CoA dehydrogenase gene, and guidelines for the bioc
106                                  Short chain acyl-CoA dehydrogenase has maximal activity toward butyr
107                          Comparison to other acyl-CoA dehydrogenases has provided additional insight
108 otein complex decreased, indicating that the acyl-CoA dehydrogenases have the ability to compete with
109                                  Short-chain acyl-CoA dehydrogenase (hSCAD) catalyzes the first matri
110                            Human short-chain acyl-CoA dehydrogenase (hSCAD) catalyzes the first matri
111 on-transfer properties of human medium-chain acyl-CoA dehydrogenase (hwtMCADH) has been studied using
112 gene regulation of ACAD9 and very-long-chain acyl-CoA dehydrogenase identify the presence of two inde
113  defects have been identified in most of the acyl-CoA dehydrogenases in humans.
114 ydrogenase is also differentiated from other acyl-CoA dehydrogenases in that the catalytic base must
115 atty acids and stimulated gene expression of acyl-CoA dehydrogenases in the liver.
116 g chain acyl-CoA synthetase, very long chain acyl-CoA dehydrogenase) in livers of the ethanol-fed ani
117  of thioester substrates in the medium-chain acyl-CoA dehydrogenase involves alpha-proton abstraction
118                                  Short chain acyl-CoA dehydrogenase is a homotetramer with a subunit
119                             The medium chain acyl-CoA dehydrogenase is rapidly inhibited by racemic 3
120         The overall structure of short chain acyl-CoA dehydrogenase is very similar to those of mediu
121 ed desolvation within the active site of the acyl-CoA dehydrogenases is discussed.
122 efines a side of the binding cavity in other acyl-CoA dehydrogenases is replaced by a leucine (Leu-37
123 ase is very similar to those of medium chain acyl-CoA dehydrogenase, isovaleryl-CoA dehydrogenase, an
124       Crystal structures of human long-chain acyl-CoA dehydrogenase (LCAD) and the catalytically inac
125                A kinetic study of long-chain acyl-CoA dehydrogenase (LCAD) and very long-chain acyl-C
126                                   Long-chain acyl-CoA dehydrogenase (LCAD) catalyzes the initial step
127 y, none have been documented with long-chain acyl-CoA dehydrogenase (LCAD) deficiency.
128                                   Long-chain acyl-CoA dehydrogenase (LCAD) is a key mitochondrial fat
129                                   Long-chain acyl-CoA dehydrogenase (LCAD) is a mitochondrial fatty a
130 studied mice with a deficiency of long-chain acyl-CoA dehydrogenase (LCAD), a key enzyme in mitochond
131 chondrial C(12) oxidation enzyme, long-chain acyl-CoA dehydrogenase (LCAD), also developed periportal
132 genase (IVD), and Glu261 in human long chain acyl-CoA dehydrogenase (LCAD), has been suggested to aff
133 g the fatty acid oxidation enzyme long-chain acyl-CoA dehydrogenase (LCAD).
134 ement has been altered to that of long chain acyl-CoA dehydrogenase (LCADH), Glu376Gly/Thr255Glu, hav
135 catabolism that is salvaged by the dedicated acyl-CoA dehydrogenase-like flavoenzyme TdaE.
136 nheme FeII-dependent halogenase KtzD and the acyl-CoA dehydrogenase-like flavoprotein KtzA, proposed
137 T2 cells via deleting either Cpt1a or Acadl (acyl-CoA dehydrogenase long chain) restricts alveolar in
138 been performed on the wild-type medium-chain acyl-CoA dehydrogenase (MCAD) and two of its mutant form
139 g of octenoyl-CoA to pig kidney medium chain acyl-CoA dehydrogenase (MCAD) by isothermal titration mi
140                                 Medium-chain acyl-CoA dehydrogenase (MCAD) catalyzes the flavin-depen
141                                 Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most com
142 ox and ionization properties of medium-chain acyl-CoA dehydrogenase (MCAD) from pig kidney.
143 ctive site residue, Glu-376, of medium-chain acyl-CoA dehydrogenase (MCAD) has been known to abstract
144  fatty acid synthase (FASN) and medium chain acyl-CoA dehydrogenase (MCAD) protein within the same ce
145 376 --> Asp (E376D) mutation in medium chain acyl-CoA dehydrogenase (MCAD), creates a complementary c
146 identified as Glu376 in porcine medium chain acyl-CoA dehydrogenase (MCAD), Glu254 in human isovalery
147 octynoyl-CoA (inactivator) with medium chain acyl-CoA dehydrogenase (MCAD), were essentially identica
148 in regulating the gene encoding medium-chain acyl-CoA dehydrogenase (MCAD), which catalyzes the initi
149                 The human liver medium chain acyl-CoA dehydrogenase (MCAD)-catalyzed reaction proceed
150  in the recombinant human liver medium-chain acyl-CoA dehydrogenase (MCAD)-catalyzed reaction, we bec
151 here it directly interacts with medium-chain acyl-CoA dehydrogenase (MCAD).
152 model between human ETF and pig medium-chain acyl-CoA dehydrogenase (MCAD).
153 oleacryloyl-CoA) to human liver medium-chain acyl-CoA dehydrogenase (MCAD).
154 oup) upon binding to pig kidney medium-chain acyl-CoA dehydrogenase (MCAD).
155  phenylpropionic acid involving medium-chain acyl-CoA dehydrogenase (MCAD).
156  of the soluble ACADs including medium-chain acyl-CoA dehydrogenase (MCAD).
157 gion of the gene encoding human medium-chain acyl-CoA dehydrogenase (MCAD, which catalyzes a rate-lim
158 ructures of the wild type human medium-chain acyl-CoA dehydrogenase (MCADH) and a double mutant in wh
159                       ATP content and medium Acyl-CoA dehydrogenase mRNA were lower in RXRalpha mutan
160 ter introduction of a 2-trans-double bond by acyl-CoA dehydrogenase or acyl-CoA oxidase, the resultan
161 es were reduced (long chain and medium chain acyl-CoA dehydrogenases) or failed to be induced (acyl-C
162 polipoprotein AI, AII, or CIII; medium chain acyl-CoA dehydrogenase; or stearoyl-CoA desaturase mRNAs
163 trate-binding cavity relative to short-chain acyl-CoA dehydrogenase, permitting the optimal binding o
164     Moreover, the FAO enzyme very-long-chain acyl-CoA dehydrogenase physically interacted with TFP, t
165  synthases (pltB, pltC), an acyl coenzyme A (acyl-CoA) dehydrogenase (pltE), an acyl-CoA synthetase (
166 n the reaction catalyzed by pig medium-chain acyl-CoA dehydrogenase (pMCAD) has been investigated usi
167             With the exception of long-chain acyl-CoA dehydrogenase protein level, which was increase
168       Comparing the structures of four other acyl-CoA dehydrogenases provides further insights into t
169 tative mitochondria-targeted, bacterial-type acyl-CoA dehydrogenase (PtMACAD1) that is present in Str
170 se), 3-hydroxybutyryl-CoA dehydrogenase, and acyl-CoA dehydrogenase, respectively.
171 CoA dehydrogenase (LCAD) and very long-chain acyl-CoA dehydrogenase revealed that 5-trans-tetradeceno
172 ns is dehydrogenated by short/branched-chain acyl-CoA dehydrogenase (SBCAD).
173                     Rat short/branched chain acyl-CoA dehydrogenases (SBCAD) are more active toward s
174                                  Short chain acyl-CoA dehydrogenase (SCAD) is a homotetrameric flavoe
175 f liver-specific expression of a short-chain acyl-CoA dehydrogenase (SCAD) transgene in the SCAD-defi
176 late on substrate specificity in short chain acyl-CoA dehydrogenase (SCAD).
177  and E376Q mutants of the human medium chain acyl-CoA dehydrogenase showed that these two active site
178 te of FkbI reveal key differences from other acyl-CoA dehydrogenases, suggesting that FkbI may recogn
179 , which bears superficial resemblance to the acyl-CoA dehydrogenase superfamily of flavoproteins.
180  Structurally, the enzyme is a member of the acyl-CoA dehydrogenase superfamily.
181  places it into the well-characterized fatty acyl-CoA dehydrogenase superfamily.
182 nzyme nitroalkane oxidase is a member of the acyl-CoA dehydrogenase superfamily.
183 arget the FAD of the medium- and short-chain acyl-CoA dehydrogenases support this conclusion.
184  regulatory circuit involving a heat-induced acyl-CoA dehydrogenase that controls the lipid saturatio
185 drogenase 9 (ACAD9) is a recently identified acyl-CoA dehydrogenase that demonstrates maximum activit
186 longs to an important flavoprotein family of acyl-CoA dehydrogenases that catalyze the alpha,beta-deh
187  detectable semiquinone; however, like other acyl-CoA dehydrogenases, the human enzyme stabilizes an
188  mV), the greatest magnitude measured in any acyl-CoA dehydrogenase to date.
189 er flavoprotein that shuttles electrons from acyl-CoA dehydrogenases to coenzyme Q.
190 ydrogenase kinase, medium-chain length fatty acyl-CoA dehydrogenase, ubiquinone-cytochrome c reductas
191 the two human genes encoding very long chain acyl-CoA dehydrogenase (VLCAD) and postsynaptic density
192                              Very-long-chain acyl-CoA dehydrogenase (VLCAD) catalyzes the first step
193                                    Very long acyl-CoA dehydrogenase (VLCAD) deficiency is a genetic p
194                              Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is an inherite
195                              Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is the most co
196 ents have been found to have very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency, none have bee
197 hibit down-regulation of the very-long-chain acyl-CoA dehydrogenase (VLCAD) enzyme, which exacerbates
198                              Very-long-chain acyl-CoA dehydrogenase (VLCAD) is a major enzyme catalys
199                              Very-long-chain acyl-CoA dehydrogenase (VLCAD) is a member of the family
200                              Very long-chain acyl-CoA dehydrogenase (VLCAD) is an inner mitochondrial
201                              Very long chain acyl-CoA dehydrogenase (VLCAD; ACADVL) was found to be o
202 s highly homologous to human very-long-chain acyl-CoA dehydrogenase was identified by large-scale ran
203 hydrogenase family member, human short chain acyl-CoA dehydrogenase, was incubated with dimethylglyci
204     With the known structure of medium chain acyl-CoA dehydrogenase, we hypothesize a possible struct
205 the fatty acid oxidation enzyme medium-chain acyl-CoA dehydrogenase, we tested whether acetylation-de
206 nitine palmitoyltransferase and medium-chain acyl-CoA dehydrogenase were unaltered with fasting.
207 -CoAs are poor substrates of very long-chain acyl-CoA dehydrogenase when compared with myristoyl-CoA.
208  ETF catalyzed by sarcosine and medium chain acyl-CoA dehydrogenases which reduce the flavin to the s
209  near Acads, a gene encoding the short chain acyl CoA dehydrogenase, which is mutated in BALB/cByJ mi
210 vity and steady-state levels of medium-chain acyl-CoA dehydrogenase, which catalyzes a rate-limiting
211 loning revealed that IBR3 encodes a putative acyl-CoA dehydrogenase with a consensus peroxisomal targ
212 CoA dehydrogenase, and bacterial short chain acyl-CoA dehydrogenase with a three-domain structure com
213                 The turnover of medium chain acyl-CoA dehydrogenase with native ETF and ETF containin

 
Page Top